“Portal hypertension after prolonged use of trastuzumab emtansine: nodular regenerative hyperplasia with autoimmune features”, RSD, vol. 10, no. 8, p. e10810817005, Jul. 2021, doi: 10.33448/rsd-v10i8.17005.